Oracle Health announced native AI capabilities across its revenue cycle management portfolio on 23 September 2026 at the Oracle Health and Life Sciences Summit in Orlando, with general availability planned for the coming months, the company said in a press release.
Key points
- AI features span prior authorization, clinical document quality integrity, charge capture and integrity, medical coding for professional fees, and appeal management
- Capabilities embedded across existing Oracle Health revenue cycle solutions; organizations can modernize at their own pace
- Seema Verma says AI brings comprehensive revenue cycle solution across front, middle and back office
- Planned product direction includes connecting reimbursement workflows with Oracle Fusion Cloud Applications
- Oracle stock traded at USD 148.85 on 23 September, down 0.18% on the day, market cap $451.14 billion
AI embedded across the revenue cycle
The new capabilities target the full patient and payment journey. Prior authorization checks coverage, retrieves documentation requirements, pre-fills information, attaches evidence and coordinates payer interactions. Clinical document quality integrity reviews reimbursement-related documentation, identifies gaps and surfaces contextual recommendations. Charge capture and integrity examines clinical and reimbursement circumstances, qualifiers and components within charge review workflows. Medical coding for professional fees reviews clinical documentation and patient circumstances to generate coding recommendations. Appeal management analyzes remittance, identifies payment variances and automates appeal packet creation when a decision to appeal is made.
Oracle Health said organizations can leverage the native AI embedded across existing revenue cycle solutions while modernizing at their own pace. The company described the approach as bringing AI upstream — across scheduling, financial clearance, clinical documentation, charge capture, billing and payment — to identify risks before they lead to payment delays and revenue loss.
Seema Verma on comprehensive solution
“AI gives us an opportunity to prevent revenue cycle problems before they lead to denials and delayed payments,” said Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences. “Oracle Health is delivering a comprehensive revenue cycle solution that brings AI across the front, middle and back office, connecting clinical and financial workflows from the first patient interaction through payment.”
Connection to enterprise financial operations planned
As part of its planned product direction, Oracle Health aims to link reimbursement workflows more closely with enterprise financial operations, covering financial settlement, revenue recording, cash management and data analysis via offerings like Oracle Fusion Cloud Applications. The company said this can assist healthcare organizations in linking reimbursement processes, financial functions and enterprise data analysis to enable better operational and financial choices. A future product disclaimer in the release noted that the outlined direction is for information purposes only, may not be incorporated into any contract, and remains at the sole discretion of Oracle Corporation.
Clinical AI Agent for nurses launched 14 September
The announcement follows Oracle Health’s 14 September launch of the US commercial availability of its Clinical AI Agent for nurses, embedding voice-driven and generative AI capabilities into the inpatient Oracle Health Foundation EHR. That rollout targeted the largest clinical workforce in inpatient settings, with BayCare Health System in Florida among early adopters evaluating the system in active inpatient units.
Oracle Corporation’s stock was trading at USD 148.85 on 23 September 2026, showing a slight 0.18% decline in one day, with a market cap of $451.14 billion.
.jpg){kind=link}